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The clinical features associated with HIV in Adamawa
State north eastern Nigeria was done clinically and bacte-
riologically using Ridley-Jopling classification and bacte-
riological index respectively. The cases were classified as
paucibacillary (Tuberculoid – TT and Borderline Tubercu-
loid – BTT) and multibacillary (Borderline Borderline –
BB, Borderline Lepromatous – BL and Lepromatous Lep-
rosy – LL) Leprosy.
Eleven (10%) of 104 cases were HIV seropositive compris-
ing 7 males and 4 female. Age range was 14 and 63.
Among the HIV seropositive patients, those with pauci-
bacillary (PB) were 6 (TT -1, BT -5) while multibacillary
(MB) Leprosy 5 (BB-1), BL -2, LL-2). The predominant
clinical feature were clawing fingers (64%) ulceration
(64%), hand muscle atrophy (5%) and clawing toes
(45%). Some clinical feature of paucibacillary leprosy
such as sensory loss and hair losses as is also seen in HIV
negative patients occurred in increase frequency in HIV
positive patients belonging to the multibacillary class. The
HIV infected leprosy patients are more likely to manifest
advanced stages of the disease than HIV seronegative
patient.
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